LINC00351: A Drug Target / Disease Biomarker (G100874137)

Target Name: LINC00351

NCBI ID: G100874137

LINC00351

Other Name(s): long intergenic non-protein coding RNA 351 | Long intergenic non-protein coding RNA 351

LINC00351: A Drug Target / Disease Biomarker

LINC00351 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is long non-coding RNA-protein LINC00351, and it is also known as hnRNA0001. The protein encoded by this gene is a negative regulator of the gene encoding the RNA polymerase II enzyme, which is responsible for transcribing DNA into RNA.

LINC00351 is a non-coding RNA that is derived from the RNA polymerase II gene. It is characterized by the presence of a long non-coding RNA-protein structure, which is composed of multiple exons. The full-length hnRNA0001 gene encodes a protein of approximately 210 amino acids.

The function of LINC00351 is not well understood, but it is known to play a role in the regulation of gene expression. It is expressed in various tissues of the body, including the brain, heart, and kidneys, and it is also expressed in various cell types, including neurons and glial cells.

One of the unique features of LINC00351 is its ability to interact with the RNA polymerase II enzyme. This interaction allows the protein to regulate the activity of the enzyme and influence the expression of genes in the cell. LINC00351 is also known to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

In addition to its role in gene regulation, LINC00351 is also a potential drug target. Its interaction with the RNA polymerase II enzyme makes it a potential target for small molecules that can modulate the activity of the enzyme. This could lead to new treatments for a variety of diseases, including cancer, neurodegenerative diseases, and inflammatory disorders.

The discovery and characterization of LINC00351 has been made using a variety of techniques, including RNA sequencing and biochemical assays. Studies have shown that LINC00351 is expressed in various tissues of the body and that it plays a role in the regulation of gene expression. Additionally, studies have also shown that LINC00351 can interact with the RNA polymerase II enzyme and that it is a potential drug target.

In conclusion, LINC00351 is a non-coding RNA-protein that is expressed in various tissues of the body. Its function is not well understood, but it is known to play a role in the regulation of gene expression and it is a potential drug target. Further research is needed to fully understand the role of LINC00351 in cellular processes and to develop new treatments for diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 351

The "LINC00351 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00351 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets